| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1755-3768.1983.TB01401.X |
| P698 | PubMed publication ID | 6687972 |
| P2093 | author name string | J P Gilbard | |
| R L Farris | |||
| P433 | issue | 1 | |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 108-116 | |
| P577 | publication date | 1983-02-01 | |
| P1433 | published in | Acta ophthalmologica | Q27708761 |
| P1476 | title | Ocular surface drying and tear film osmolarity in thyroid eye disease | |
| P478 | volume | 61 |
| Q92462109 | An assessment of the ocular tear film in patients with thyroid disorders |
| Q44000520 | An electrolyte-based solution that increases corneal glycogen and conjunctival goblet-cell density in a rabbit model for keratoconjunctivitis sicca |
| Q60919214 | Assessment of tear-evaporation rate in thyroid-gland patients |
| Q34432436 | Blinking is controlled primarily by ocular surface conditions |
| Q33647383 | Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach |
| Q34164566 | Decreased tear osmolarity and absence of the inferior marginal tear strip following sleep |
| Q37108158 | Diagnosis and stage of Graves' ophthalmopathy: Efficacy of quantitative measurements of the lacrimal gland based on 3-T magnetic resonance imaging |
| Q34391935 | Diagnosis of dry eye. |
| Q34338027 | Effect of inflammation on lacrimal gland function. |
| Q33645457 | Effect of osmolarity of artificial tear drops on relief of dry eye symptoms: BJ6 and beyond |
| Q33252114 | In vivo confocal laser scanning microscopy of the cornea in dry eye. |
| Q41914257 | Increased tear secretion in pancreatic cholera: a newly recognized symptom in an experiment of nature |
| Q82717721 | Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy |
| Q52501417 | Morphologic effect of hyperosmolarity on rabbit corneal epithelium. |
| Q37682318 | Ocular surface effects of thyroid disease. |
| Q84756814 | Ocular surface inflammation, and nerve growth factor level in tears in active thyroid-associated ophthalmopathy |
| Q69582729 | Open-label crossover study of vitamin A ointment as a treatment for keratoconjunctivitis sicca |
| Q41735066 | Ophthalmologic aspects of thyroid-related orbitopathy |
| Q35544113 | Ophthalmological evaluation in thyroid‐associated ophthalmopathy |
| Q43085297 | Presence of Dry Eye in Patients with Hashimoto's Thyroiditis. |
| Q73412844 | Relation between tear breakup time and spontaneous blink rate |
| Q56775906 | Stress-activated protein kinase signaling pathways in dry eye and ocular surface disease |
| Q50103628 | Subjective Complaints of Ocular Dryness and Xerostomia Among the Non-Sjögren Adult Population of Lublin Region, Poland. |
| Q38652990 | TFOS DEWS II Tear Film Report. |
| Q34164909 | Tear analysis in contact lens wearers |
| Q39549123 | Tear diluents in the treatment of keratoconjunctivitis sicca |
| Q68777259 | Tear film and ocular surface changes in a rabbit model of neurotrophic keratitis |
| Q81933508 | Tear film osmolarity in patients with thyroid ophthalmopathy |
| Q43618900 | Tear film profile in Graves' ophthalmopathy |
| Q34164990 | Tear osmolarity variation in the dry eye. |
| Q36811289 | The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy |
| Q37325127 | The Change of Lacrimal Gland Volume in Korean Patients with Thyroid-associated Ophthalmopathy |
| Q48503358 | The Doyne Lecture. Reflections on the tears. |
| Q57648466 | The contribution of meibomian disease to dry eye |
| Q80347907 | The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007) |
| Q53684503 | The function and morphology of Meibomian glands in patients with thyroid eye disease: a preliminary study. |
| Q47563654 | The levels of 12 cytokines and growth factors in tears: hyperthyreosis vs euthyreosis. |
| Q34093781 | The ocular surface and tear film and their dysfunction in dry eye disease |
| Q37781259 | The ocular surface in thyroid diseases |
| Q69470763 | The permeability of the corneal epithelium of Graves' ophthalmopathy as determined by fluorophotometry |
| Q34871250 | The relationship between Graves' ophthalmopathy and dry eye syndrome |
| Q34220709 | Thyroid associated ophthalmopathy - a review |
| Q77464502 | Thyroid associated ophthalmopathy: botulinum toxin A in the treatment of upper eyelid retraction--a pilot study |
| Q35919247 | Thyroid associated orbitopathy. |
| Q84735553 | Topical cyclosporine A for the dry eye findings of thyroid orbitopathy patients |
| Q37406589 | Update on thyroid eye disease and management. |
| Q33802192 | Update on thyroid-associated Ophthalmopathy with a special emphasis on the ocular surface |
| Q79926756 | [Osmoprotection as a new therapeutic principle] |
| Q34481014 | c-Jun NH2-terminal kinase mediates interleukin-1beta-induced inhibition of lacrimal gland secretion. |
Search more.